286 related articles for article (PubMed ID: 36740704)
1. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
2. The expression and role of glycolysis-associated molecules in infantile hemangioma.
Chen J; Wu D; Dong Z; Chen A; Liu S
Life Sci; 2020 Oct; 259():118215. PubMed ID: 32768579
[TBL] [Abstract][Full Text] [Related]
3. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
[TBL] [Abstract][Full Text] [Related]
4. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
6. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
8.
Lou L; Chen G; Zhong B; Liu F
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31383785
[No Abstract] [Full Text] [Related]
9. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.
Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H
Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846
[TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
Liu X; Zhao Y; Zhang E; Yan H; Lv N; Cai Z
Biochem Biophys Res Commun; 2019 Jul; 515(2):332-338. PubMed ID: 31153642
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss.
Wang J; Guan H; Liu H; Lei Z; Kang H; Guo Q; Dong Y; Liu H; Sun Y; Fang Z; Li F
J Cell Mol Med; 2020 Feb; 24(3):2294-2307. PubMed ID: 31880389
[TBL] [Abstract][Full Text] [Related]
12. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
13. Effects of propranolol on glucose metabolism in hemangioma-derived endothelial cells.
Yang K; Li X; Qiu T; Zhou J; Gong X; Lan Y; Ji Y
Biochem Pharmacol; 2023 Dec; 218():115922. PubMed ID: 37956892
[TBL] [Abstract][Full Text] [Related]
14. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
Jones BC; Pohlmann PR; Clarke R; Sengupta S
Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy.
Horváthová J; Moravčík R; Matúšková M; Šišovský V; Boháč A; Zeman M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922320
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGFBI in infantile hemangioma tissues and its effect on the biological characteristics of hemangioma endothelial cells.
Li M; Yang E; Li Y; Geng Y; Wu H; Zhang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):29-36. PubMed ID: 38596938
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
[TBL] [Abstract][Full Text] [Related]
18. OTUB1 Catalytic-Independently Deubiquitinates TGFBI and Mediates the Angiogenesis in Infantile Hemangioma by Regulating Glycolysis.
Li M; Wang X; Yang E; Li Y; Geng Y; Chen Z; Huang S; Zhang D; Wu H
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):654-673. PubMed ID: 36994729
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma.
Matsumoto K; Noda T; Kobayashi S; Sakano Y; Yokota Y; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Eguchi H
Cancer Lett; 2021 Mar; 500():29-40. PubMed ID: 33307155
[TBL] [Abstract][Full Text] [Related]
20. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis.
Feng Y; Zou R; Zhang X; Shen M; Chen X; Wang J; Niu W; Yuan Y; Yuan F
Angiogenesis; 2021 Aug; 24(3):489-504. PubMed ID: 33400016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]